{"id":6432,"date":"2020-08-07T11:29:23","date_gmt":"2020-08-07T10:29:23","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=6432"},"modified":"2020-08-07T11:29:23","modified_gmt":"2020-08-07T10:29:23","slug":"the-rise-of-ai-in-medical-imaging-technologies","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/the-rise-of-ai-in-medical-imaging-technologies\/6432\/","title":{"rendered":"The rise of AI in medical imaging technologies"},"content":{"rendered":"
The report by Data Bridge Market Research<\/a> suggests that global market for Artificial Intelligence (AI) in medical imaging is estimated to hit $264.85bn by 2026, registering a CAGR of 36.89% between 2019 and 2026.<\/p>\n The report attributes the projected success to higher rates of conclusive diagnosis procedures with the application of AI in medical imaging. The use of AI in medical imaging also facilitates the rise of personalised treatment rather than a \u2018one-size-fits-all\u2019 approach.<\/p>\n One major factor influencing the adoption of AI in medical imaging is its proven success in diagnosing and staging cancers<\/a>. The Cancer Prevention and Research Institute of Texas recently granted an independent medical technology provider, Perimeter Medical Imaging, $7.4m to develop AI technology that can identify sub-surface breast cancers.<\/p>\n Sentinel lymph node biopsy is currently the standard method for breast cancer staging, which includes preoperative lymph node tracing and intraoperative lymph node biopsy image-guiding. However, existing image guidance techniques suffer from a variety of limitations, such as harmful ionising radiation, high cost, and poor imaging depth.<\/p>\nThe benefits of medical imaging in cancer staging<\/h3>\n